Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urodynamic effect of single vaginal application of V0162 gel in post-menopausal women with overactive bladder
2010-024271-10Phase 2Terminated
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vibegron in overactive bladder (OAB), sponsored by Pierre Fabre Laboratories. Primary endpoint: Number of detrusor contractions. Started Apr 2011; status: terminated.
02
Drugs
vibegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2010-024271-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024271-10.